MENU

LRMR Stock Tickeron detected bullish Stock Pattern: Head-and-Shoulders Bottom LRMR on October 14, 2024, netting in a 9.44% gain over 5 days

A.I.dvisor
at Tickeron.com
10/17/24
Loading...
+9.44% Gain from a Successful pattern Head-and-Shoulders Bottom
LRMR - Larimar Therapeutics
Ticker: LRMR
Company: Larimar Therapeutics
Gain: +9.44%
Confirmed: 10/14/24
Succeeded: 10/15/24
Total length: 5 days
On October 10, 2024, A.I.dvisor detected a Head-and-Shoulders Bottom Pattern (Bullish) for Larimar Therapeutics (LRMR, $6.78). On October 14, 2024, A.I.dvisor confirmed the Bullish pattern, setting a target price of $7.96. 1 day later, on October 15, 2024, LRMR reached the target price resulting in a for traders who took a long position in the stock.

LRMR in +6.35% Uptrend, advancing for three consecutive days on October 16, 2024

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where LRMR advanced for three days, in of 270 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 07, 2024. You may want to consider a long position or call options on LRMR as a result. In of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for LRMR just turned positive on October 04, 2024. Looking at past instances where LRMR's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

LRMR moved above its 50-day moving average on October 15, 2024 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The 50-day moving average for LRMR moved below the 200-day moving average on October 02, 2024. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LRMR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

LRMR broke above its upper Bollinger Band on October 16, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for LRMR entered a downward trend on October 11, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.971) is normal, around the industry mean (12.582). P/E Ratio (0.000) is within average values for comparable stocks, (110.042). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.002). LRMR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (223.593).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LRMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LRMR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
LRMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company, which engages in the research and development of a therapeutic treatment for mitochondrial disorders and Friedreich's ataxia

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Three Bala Plaza East
Phone
+1 844 511-9056
Employees
42
Web
https://www.larimartx.com